Clinical Trial Update: 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting a Phase 2/3 study in China evaluating 25-gauge vitrectomy with ranibizumab or triamcinolone acetonide for proliferative diabetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Ranibizumab (ranibizumab)
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: JUNYAN ZHANG | Conditions: Proliferative Diabetic Retinopathy | Phase 2, Phase 3 | Status: UNKNOWN